Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
    • Patient Resources
    • Eddie’s Story
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

    Healthcare, Education

    Monophasic Synovial Sarcoma of the Posterior Pharyngeal Wall: A Rare Case Study

    January 26, 2026 ayushis Comments Off on Monophasic Synovial Sarcoma of the Posterior Pharyngeal Wall: A Rare Case Study
    Three people in medical attire are standing and talking in a brightly lit hallway. The image is blurred, and there is an exclamation mark inside a triangle warning icon overlayed in the center.
    Content Warning:
    This article references a published medical case study that includes graphic surgical images involving the head and neck region. While the information may be valuable and informative, some readers may find the images difficult to view. Please proceed with care.

    Synovial sarcoma most often develops in the extremities, but in rare cases, it can arise in the head and neck region. A published case study in the European Archives of Oto-Rhino-Laryngology highlights one such rare presentation: monophasic synovial sarcoma originating in the posterior pharyngeal wall.

    Although uncommon, head and neck synovial sarcoma presents unique diagnostic and treatment challenges due to the complexity of surrounding anatomy and the critical functions involved in breathing, swallowing, and speech. Studies like this one provide valuable insight for clinicians and patients navigating these rare diagnoses.

    A rare and challenging diagnosis

    In this case, a 25-year-old patient presented with symptoms including difficulty breathing while lying down, snoring, and trouble swallowing solid foods. Initial imaging and biopsy suggested a benign tumor, a situation that is not uncommon with synovial sarcoma due to its tendency to appear well-defined and non-aggressive on early scans.

    As symptoms progressed, further imaging and pathology revealed the diagnosis of monophasic synovial sarcoma of the posterior pharyngeal wall. This highlights a known challenge with synovial sarcoma: it can closely mimic benign conditions, leading to delays in diagnosis, particularly in rare anatomical locations like the head and neck.

    Imaging and pathology findings

    Advanced imaging showed a heterogeneous mass with areas of calcification—an imaging feature seen in a subset of synovial sarcoma cases. Definitive diagnosis was confirmed through histopathology, immunohistochemistry, and cytogenetic testing, which identified the characteristic t(X;18) chromosomal translocation associated with synovial sarcoma.

    The tumor was classified as monophasic, meaning it consisted primarily of spindle-shaped cells, a subtype that is frequently misdiagnosed due to its resemblance to other soft tissue tumors.

    Surgical treatment and reconstruction

    The primary treatment approach was wide surgical excision aimed at achieving clear margins. Due to the tumor’s size and location, the surgery required complex access and reconstruction. The surgical team used a lateral trapezius flap—a less commonly used reconstructive technique—to repair the defect created after tumor removal.

    This reconstructive approach allowed restoration of the pharyngeal wall while preserving critical structures involved in swallowing and airway protection. The study highlights this technique as a potential option for large defects in similar cases.

    Role of additional therapies

    Following surgery, the patient received radiation therapy. Chemotherapy was initiated but discontinued after one cycle due to side effects. At follow-up, the patient showed no evidence of disease and was able to resume oral intake with supportive therapy.

    While the role of chemotherapy in head and neck synovial sarcoma remains debated, studies suggest that a multidisciplinary approach—including surgery, radiation, and careful long-term surveillance—offers the best chance for disease control.

    Why this study matters

    Although this case represents a single patient, it adds to a limited body of knowledge about synovial sarcoma in the head and neck region. For patients and families affected by synovial sarcoma outside of the extremities, studies like this help improve understanding of how the disease can present, how it is diagnosed, and what treatment options may look like.

    Importantly, it also reinforces the value of second opinions, specialized pathology review, and care at centers experienced with sarcoma—especially when symptoms persist despite reassurance that a mass may be benign.

    Looking ahead

    Head and neck synovial sarcoma remains rare, but continued documentation and study are essential to improving diagnosis, treatment strategies, and long-term outcomes. Research like this contributes to ongoing efforts to refine surgical techniques, explore reconstruction options, and better understand the biology of this complex disease.

    For patients navigating synovial sarcoma of the head and neck, awareness and advocacy remain critical tools—both for timely diagnosis and access to specialized care.

    Content Warning:
    This article references a published medical case study that includes graphic surgical images involving the head and neck region. While the information may be valuable and informative, some readers may find the images difficult to view. Please proceed with care. Original study here.

    For more detailed information about Synovial Sarcoma resources and support, please visit our website.

    ayushis

    Post navigation

    Previous
    Next

    Search

    Categories

    • Black Flag Racing (2)
    • Case Study (3)
    • Children (1)
    • CHOP (3)
    • Development (10)
    • Dr. Theodore Laetsch (3)
    • Education (19)
    • Europe Expansion (1)
    • Healthcare (9)
    • Latest News (12)
    • Programs (1)
    • Rare Cancer (7)
    • Rare Cancer Funding (2)
    • Research (19)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (4)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • A scientist wearing safety glasses and gloves closely examines samples through a microscope in a laboratory setting, concentrating on her research.
      Breaking Down Synovial Sarcoma’s Defenses: A study on Immune Evasion and Targeted Treatment
    • A scientist wearing a lab coat, gloves, safety goggles, and a mask examines a test tube beside a microscope in a laboratory. Another scientist works in the background. Scientific equipment and screens are visible.
      When Synovial Sarcoma Hides in Plain Sight: A Diagnostic Wake-Up Call
    • A doctor wearing a white coat and stethoscope holds a glowing light bulb in one hand, symbolizing innovation or new ideas in healthcare.
      Rare Synovial Sarcoma Cases Highlight New Limb-Sparing Reconstruction Approach

    Tags

    Advocacy in Action Afami-cel CHOP clinical trial immunotherapy localized synovial sarcoma MAGE-A4 synovial sarcoma nonprofit drug development NY-ESO-1 synovial sarcoma personalized cancer treatment precision medicine radiation therapy for synovial sarcoma Rare Cancer Rare Cancer Europe rare cancer research rare soft tissue sarcoma research sarcoma clinical trials sarcoma research sarcoma surveillance sarcoma treatment soft tissue cancer soft tissue sarcoma solitary fibrous tumor SPAGN SS18 rearrangement SS18-SSX fusion SS18::SSX STAT6 positivity Synovial Sarcoma synovial sarcoma diagnosis Synovial Sarcoma Foundation Synovial Sarcoma Italy synovial sarcoma recurrence synovial sarcoma subtypes synovial sarcoma surgery synovial sarcoma survival synovial sarcoma treatment T-Cell Therapy targeted therapy T Cell TECELRA Tecelra T-cell therapy tumor size synovial sarcoma webinar

    Related posts

    A healthcare professional in blue scrubs holds the hand of a patient in bed, offering comfort and support in a bright, sunlit room.
    Research, Rare Cancer

    Research Highlights Importance of Patient-Centered Sarcoma Surveillance

    May 22, 2026 ayushis Comments Off on Research Highlights Importance of Patient-Centered Sarcoma Surveillance

    A 2022 study explored how sarcoma patients feel about long-term surveillance imaging after treatment, highlighting the emotional, financial, and practical challenges that can come with ongoing follow-up care. The study, led by Sarah C. Tepper, Anna K. Holten, Cara A. Cipriano, and colleagues evaluated patient concerns surrounding surveillance imaging through the “Sarcoma Surveillance Survey.” The […]

    A stethoscope rests on printed charts and graphs with blue bars and lines, representing medical or healthcare statistics and data analysis.
    Rare Cancer Funding, Latest News

    North America Synovial Sarcoma Treatment Market Expected to Grow Through 2033

    May 14, 2026 ayushis Comments Off on North America Synovial Sarcoma Treatment Market Expected to Grow Through 2033

    New industry analyses project continued growth in the North America synovial sarcoma treatment market, with a predicted compound annual growth rate (CAGR) of 4.2% from 2026 to 2033. The report reflects increasing momentum in rare cancer research, including advances in targeted therapy, immunotherapy, and precision medicine for synovial sarcoma. What’s Driving Growth in Synovial Sarcoma […]

    Two doctors examine X-ray images of a human skull, one in profile and one facing forward, while discussing the results in a well-lit medical setting.
    Education, Rare Cancer

    Rare Cranial Synovial Sarcoma Case Highlights Importance of Accurate Diagnosis

    May 11, 2026 ayushis Comments Off on Rare Cranial Synovial Sarcoma Case Highlights Importance of Accurate Diagnosis

    Synovial sarcoma is a rare and aggressive soft tissue cancer that most often develops near the joints of the arms or legs. In very rare cases, however, it can appear in unusual locations — including the skull and brain region. A newly published case report describes a patient diagnosed with primary cranial synovial sarcoma who […]

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    1025 Thomas Jefferson St. NW, Suite W-3200, Washington DC 20007
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch